Press release
Global Point-of-Care Molecular Diagnostics Market to Become $5.6 Billion by 2030
The point-of-care (POC) diagnostics are medical devices used to get an immediate result in the investigation (diagnosis & monitoring) of various diseases, such as cancer, diabetes, cardiac diseases, and others. However, Molecular diagnostics involves taking DNA or RNA, the unique genetic code found in our cells, and analyzing the sequences for red flags that can pinpoint the potential emergence of a specific disease.To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/point-of-care-molecular-diagnostics-market
The point-of-care (POC) molecular diagnostics market is reported to grow significantly in the forecasted period due to rising disease prevalence and the growing technology to improve disease diagnostics in the laboratory sector in healthcare.
The market is segmented by Application (influenza, mononucleosis, respiratory infectious disease, gastrointestinal infectious disease, sexually transmitted disease, and others such as prenatal testing and endocrinology), Technology (PCR, genetic sequencing, hybridization, microarray, and INAAT), End-User (Hospitals, Homecare, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and Latin America).
COVID-19 significantly increased the global need for diagnoses. Rapid diagnostic test kits to identify the virus in clinical specimens are in high demand due to the exponential growth in COVID-19 infections. For instance, The first COVID-19 diagnostic test, Lucira COVID-19 All-In-One Test Kit for self-testing at home with quick results, received an emergency use permission (EUA) from the US Food and Drug Administration (FDA) in November 2020. It is a molecular test with a single-use goal of identifying the new coronavirus SARS-CoV-2 that produces COVID-19 due to the market's broad commercialization of POC COVID-19 diagnostics.
A full report of Point of Care Molecular Diagnostics Market available @ https://www.omrglobal.com/industry-reports/point-of-care-molecular-diagnostics-market
However, there are several limits to molecular diagnostic technology. To stop the spread of the disease, a precise diagnosis is essential. This research shed more light on the Application and limitations of molecular diagnostic tools. Product introductions are another factor in the market's growth. For instance, to increase India's molecular diagnostics capacity for COVID-19 and beyond, the Centre for Cellular and Molecular Platforms (C-CAMP) created InDx 2.0 National Diagnostics Catapult in February 2023. The Catapult, C-CAMP InDx 2.0, aims to improve India's preparedness for ongoing and upcoming pandemics and expand India's diagnostics capabilities for infectious diseases, including but not limited to COVID-19.
POC molecular diagnostics market aims to improve the diagnosis process and speed up patient treatment accurately. It will help reduce the patient's stay in healthcare facilities and help specialists treat more critical patients. In the past few decades, infectious diseases and chronic illnesses like cancer have increased. For instance, As per WHO, seasonal influenza results in 290,000-650,000 yearly mortalities globally. In 2020, WHO estimated 374 million new infections with 1 of 4 STIs: chlamydia (129 million), gonorrhea (82 million), syphilis (7.1 million), and trichomoniasis (156 million).
Rapid diagnosis and accurate treatment will help reduce the prevalence of such diseases. The market is segmented as follows.
Key Market Trends in Global Point-of-Care Molecular Diagnostics Industry
• According to OMR analysis, By Technology, sub-segment PCR held the largest market share and is projected to grow at a CAGR of 9.0% during the forecast period (2022-2030). The market share for technology sub-segments for the year 2022 is as follows-
According to OMR analysis, By Region, North America held a significant market share and is expected to grow at a CAGR of 8.3% over the forecast period (2022-2030).
The research report has an in-depth analysis of all the segments such as application, and end-user, and their market share in the global POC molecular diagnostics market for deeper insights and understanding.
The key market player in the industry is Abbott Laboratories, Becton, Dickinson, and Company, Siemens Healthineers Diagnostics, and F. Hoffmann-La Roche Ltd.'S.The report has included 20 other company profiles from the industry across the globe to understand the competitive landscape of the global POC molecular diagnostic industry.
Latest News in the Global POC Molecular Diagnostic Industry
• In March 2023, Illumina Inc., a genetic sequencing and array-based technology, announced the release of Connected Insights, a new cloud-based software enabling tertiary analysis for clinical next-generation sequencing (NGS) data.
• In February 2023, Pune-based Mylab Discovery Solutions launched three new rapid kits for the early and fast detection of sexually transmitted infections (STIs) such as Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and Syphilis. The tests to detect sexually transmitted diseases are easy to use, capable of being stored at room temperature. They can be deployed at the point of care in resource-limited settings.
• In August 2022, Roche announced the launch of the Digital LightCyclerⓇ System, Roche's first digital polymerase chain reaction (PCR) system. This next-generation system detects disease and is designed to accurately quantify trace amounts of specific DNA and RNA targets not typically detectable by conventional PCR methods.
• In May 2022, Meridian Bioscience, Inc., a provider of diagnostic testing solutions and life science raw materials, announced the continued expansion of its isothermal amplification product line with the launch of two new innovative master mixes, Lyo-Ready™ Direct DNA LAMP Saliva Mix and Lyo-Ready™ Direct RNA/DNA LAMP Saliva Mix.
Due to different market drivers, a lot is happening in the global point-of-care molecular diagnostics market in every segment. To get an in-depth understanding of the market, a custom market research report would help better. OMR has conducted diverse research in the market and created a professional report. You can also subscribe to the same for the best market trends and technology.
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Point-of-Care Molecular Diagnostics Market to Become $5.6 Billion by 2030 here
News-ID: 3171366 • Views: …
More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…

Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…

Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…

SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Molecular
Molecular Breeding Market Report 2024 - Molecular Breeding Market Size, Share An …
"The Business Research Company recently released a comprehensive report on the Global Molecular Breeding Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The molecular breeding market size…
Molecular Quality Controls: Ensuring Precision and Reliability in Molecular Diag …
Introduction
Molecular quality controls (MQCs) play a critical role in molecular diagnostics, helping laboratories and healthcare providers ensure the accuracy, reliability, and consistency of diagnostic tests. These quality controls are essential in detecting and monitoring infectious diseases, genetic disorders, cancer biomarkers, and other molecular targets. By providing standards that verify the performance of diagnostic assays, MQCs help reduce errors, minimize false results, and maintain compliance with regulatory standards. As the demand…
Molecular Diagnostic Platform Market Advancing Molecular Diagnostics with Innova …
Global Molecular Diagnostic Platform Market Overview:
The Molecular Diagnostic Platform market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Molecular Diagnostic Platform market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth…
Molecular Modeling Market - Visualizing the unseen: Molecular modeling for grou …
Newark, New Castle, USA: The "Molecular Modeling Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Molecular Modeling Market: https://www.growthplusreports.com/report/molecular-modeling-market/8615
This latest report researches the industry structure, sales, revenue,…
Molecular Diagnostics Market - Empowering healthcare through molecular precision …
Newark, New Castle, USA: The "Molecular Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Molecular Diagnostics Market: https://www.growthplusreports.com/report/molecular-diagnostics-market/7674
This latest report researches the industry structure, sales, revenue,…
Molecular Imaging Device Market scenario for 2022 | Trivitron Healthcare, Molecu …
The Molecular Imaging Device market report anticipate the market growth and recent developments in market competition which helps players to strategies and analysis the position in Molecular Imaging Device market. It also indicates the risk factors, advancements, market drivers, revenue, business scenario, growth potential, market scope, new trends, and historical data of Molecular Imaging Device market. With this futuristic approach researchers also provides a close study of market forecast, overview…